Corrigendum to 'Efficacy + safety of palbociclib (P) in patients (pts) ≤50 y with hormone receptor‒positive (HR+)/human epidermal growth factor receptor 2‒negative (HER2–) advanced breast cancer (ABC): Subgroup analysis of 2 randomized phase 3 studies' [Breast 41S1 (2018) S11–12]
| Autor: | Massimo Cristofanilli, Nadia Harbeck, Hope S. Rugo, Aurelio Castrellon, Anil Abraham Joy, Sunil Verma, Seock-Ah Im, Shrividya Iyer, Kathy Puyana Theall, Eric Gauthier, Xin Huang, Cynthia Huang Bartlett, Sibylle Loibl, Richard S. Finn |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Breast, Vol 49, Iss , Pp 131- (2020) |
| Druh dokumentu: | article |
| ISSN: | 1532-3080 |
| DOI: | 10.1016/j.breast.2019.11.010 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|
Full Text from ScienceDirect